Trial intelligence / Profile preview

Intra-articular Dysport for knee osteoarthritis

IRCT20180416039323N1Phase 2Completed

Sponsor
Aja University of Medical Sciences
Start
Apr 2018
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of botulinum toxin type A in knee osteoarthritis (OA), sponsored by Aja University of Medical Sciences. Primary endpoints: Pain, Symptoms and 2 more. Started Apr 2018; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on IRCT20180416039323N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180416039323N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call